Log In
BCIQ
Print this Print this
 

SUN-K954

  Manage Alerts
Collapse Summary General Information
Company Sun Pharma Advanced Research Company Ltd.
DescriptionBCR-ABL tyrosine kinase inhibitors
Molecular Target BCR-ABL tyrosine kinase (BCR-ABL)
Mechanism of ActionBCR-ABL tyrosine kinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationChronic myelogenous leukemia (CML)
Indication DetailsTreat chronic myelogenous leukemia (CML)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today